Phase 4 Transplant Recipient Clinical Trials
8 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–8 of 8 trials
Recruiting
Phase 4
Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit for Septic Shock and/or Acute Respiratory Failure
Acute Respiratory FailureKidney Transplant RecipientsSepsis and septic shock+1 more
University Hospital, Strasbourg, France212 enrolled1 locationNCT06881927
Recruiting
Phase 4
Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients
Old AgeKidney Transplant Recipients
Massachusetts General Hospital92 enrolled1 locationNCT06751992
Recruiting
Phase 4
Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients
CMVLung Transplant Recipient
University Health Network, Toronto40 enrolled1 locationNCT07235683
Recruiting
Phase 4
Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors
Hepatitis B Virus (HBV)Lung Transplant Recipient
University Health Network, Toronto20 enrolled1 locationNCT07189377
Recruiting
Phase 4
Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus
Kidney Disease, ChronicImmunosuppressionTransplant Recipient (Kidney)
Instituto de Investigación Hospital Universitario La Paz114 enrolled1 locationNCT06701825
Recruiting
Phase 4
Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients
NeutropeniaCytomegalovirus InfectionsInfection in Solid Organ Transplant Recipients+1 more
Tufts Medical Center25 enrolled1 locationNCT05626530
Completed
Phase 4
Calcium supplementation and its effect on bone loss in renal transplant recipients.
Bone loss in renal transplant recipients.Hyperparathyroidism in renal transplant recipients.
Dr Patrick T Coates35 enrolled1 locationACTRN12609000250235
Completed
Phase 4
Preemptive therapy vs valacyclovir prophylaxis for cytomegalovirus (CMV) disease after renal transplantation
Cytomegalovirus disease in renal transplant recipients
Tomas Reischig, M.D., Ph.D.60 enrolled1 locationACTRN12610000015044